{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:45:11Z","timestamp":1764402311222},"reference-count":23,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1080\/00365540410020884","type":"journal-article","created":{"date-parts":[[2004,10,18]],"date-time":"2004-10-18T18:21:05Z","timestamp":1098123665000},"page":"221-229","source":"Crossref","is-referenced-by-count":26,"title":["A fourth dose of DTPa-IPV vaccine given to 4\u20136 year old children in Italy and Sweden following primary vaccination at 3, 5 and 11\u201312 months of age"],"prefix":"10.1080","volume":"37","author":[{"given":"Lennart","family":"Nilsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Faldella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne-Marie","family":"Jacquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jann","family":"Storsaeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven-Arne","family":"Silfverdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leif","family":"Ekholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0264-410X(02)00777-6","volume":"21","author":"Olin P","year":"2003","journal-title":"Vaccine"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/S0264-410X(03)00062-8","volume":"21","author":"van der Wielen M","year":"2003","journal-title":"Vaccine"},{"key":"CIT0004","first-page":"581","volume":"26","author":"Torvaldsen S","year":"2002","journal-title":"Using the Australian Childhood Immunisation Register to track the transition from whole-cell to acellular pertussis vaccines. Commun Dis Intell"},{"key":"CIT0005","first-page":"635","volume":"280","author":"He Q","year":"1998","journal-title":"Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. J Am Med Assoc"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1086\/340280","volume":"185","author":"Skowronski D","year":"2002","journal-title":"J Infect Dis"},{"key":"CIT0007","first-page":"641","volume":"20","author":"Campins-Marti M","year":"2002","journal-title":"al. and International Consensus Group on Pertussis Immunisation. Recommendations are needed for adolescent and adult pertussis immunization: rationale and strategies for consideration. Vaccine"},{"key":"CIT0011","first-page":"15","volume":"1998","author":"Institut pour le D\u00e9veloppement de l\u2019Epid\u00e9miologie Appliqu\u00e9e.","year":"1998","journal-title":"Bulletin Epid\u00e9miologique hebdomadaire(BEH)"},{"key":"CIT0013","first-page":"189","volume":"2","author":"Miyamura K","year":"1974","journal-title":"Kono R. Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells: I. Studies on factors affecting the toxin and antitoxin titration. J Biol Stand"},{"key":"CIT0014","first-page":"203","volume":"2","author":"Miyamura K","year":"1974","journal-title":"Kono R. Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells: II. Comparison with rabbit skin method and practical application for seroepidemiological studies. J Biol Stand"},{"key":"CIT0015","first-page":"137","volume":"11","author":"Melville-Smith M","year":"1983","journal-title":"A comparison of an enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera. J Biol Stand"},{"key":"CIT0017","first-page":"253","volume":"74","author":"World Health Organization","year":"1996","journal-title":"Oman and Thailand. Bulletin of the World Health Organization"},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/sim.4780040211","volume":"4","author":"Miettinen O","year":"1985","journal-title":"Stat Med"},{"key":"CIT0019","first-page":"772","volume":"20","author":"Camargo M","year":"1984","journal-title":"Immunoenzymatic assay of anti-diphtheric toxin antibodies in human serum. J Clin Microbiol"},{"key":"CIT0020","first-page":"628","volume":"5","author":"Skogen V","year":"1999","journal-title":"Detection of diphtheria antitoxin by four different methods. Clin Microbiol Infect"},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0022-3476(97)70247-6","volume":"130","author":"Schmitt H","year":"1997","journal-title":"J Pediatr"},{"key":"CIT0023","first-page":"1","volume":"107","author":"Tozzi A","year":"2001","journal-title":"Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines. Pediatrics"},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.105.4.753","volume":"105","author":"Pichichero M","year":"2000","journal-title":"Pediatrics"},{"key":"CIT0025","first-page":"e453","volume":"112","author":"Skowronski D","year":"2003","journal-title":"Scheifele D. Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity, and anticipated impact. Pediatrics"},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00006454-199909000-00006","volume":"18","author":"Halperin S","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"CIT0028","first-page":"2298","volume":"21","author":"Halperin S","year":"2003","journal-title":"Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine. Vaccine"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(98)03488-6","volume":"353","author":"Vitek C","year":"1999","journal-title":"Lancet"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0264-410X(00)00176-6","volume":"19","author":"Skogen V","year":"2000","journal-title":"Vaccine"},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/S0950268899004161","volume":"125","author":"Edmunds W","year":"2000","journal-title":"The sero-epidemiology of diphtheria in Western Europe. Epidemiol Infect"}],"container-title":["Scandinavian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00365540410020884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T10:50:09Z","timestamp":1497610209000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00365540410020884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,7,8]]},"published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1080\/00365540410020884"],"URL":"https:\/\/doi.org\/10.1080\/00365540410020884","relation":{},"ISSN":["0036-5548","1651-1980"],"issn-type":[{"value":"0036-5548","type":"print"},{"value":"1651-1980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}